/
Graduate  Entry Tuesday Graduate  Entry Tuesday

Graduate Entry Tuesday - PowerPoint Presentation

trinity
trinity . @trinity
Follow
0 views
Uploaded On 2024-03-13

Graduate Entry Tuesday - PPT Presentation

4 December 2012 Introduction to the alimentary system T he burden of GI diseases Professor Julian Walters Gastroenterology Overview The organs of the alimentary tract Symptoms and signs ID: 1047876

tract amp disease digestive amp tract digestive disease diseases symptoms population liver chronic 000 million people year mortality tractliver

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Graduate Entry Tuesday" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

1. Graduate EntryTuesday 4 December 2012Introduction to the alimentary systemThe burden of GI diseasesProfessor Julian WaltersGastroenterology

2. OverviewThe organs of the alimentary tractSymptoms and signs What are the main diseases of the GI tract and liverThe economic burden of GI and liver diseases

3. Organs of the Alimentary SystemMouth and OesophagusStomachDuodenumLiverBiliary systemPancreasSmall intestine duodenum, jejunum & ileumLarge intestinecolon, rectum & anus

4. Functions of the Alimentary SystemDigestion of foodAbsorption of nutrientsMotility from mouth to anusBarrier Immunological EndocrineMetabolic

5. GI tractHistoryExamination

6. Symptoms of Digestive DiseasesGeneralUpper GI TractLiver & BiliaryMid GI Tract & PancreasLower GI Tract

7. Symptoms of Digestive DiseasesGeneralAnorexiaWeight lossAnaemiaUpper GI TractLiver & BiliaryMid GI Tract & PancreasLower GI Tract

8. Symptoms of Digestive DiseasesGeneralUpper GI TractHaematemesis and MelaenaNausea & vomitingDysphagia, odynophagiaHeartburn, acid regurgitation & belchingChest pain Epigastric painLiver & BiliaryMid GI Tract & PancreasLower GI Tract

9. Symptoms of Digestive DiseasesGeneralUpper GI TractLiver & BiliaryRUQ pain Biliary ColicJaundiceDark Urine / pale stoolAbdominal distension (Ascites)Mid GI Tract & PancreasLower GI Tract

10. Symptoms of Digestive DiseasesGeneralUpper GI TractLiver & BiliaryMid GI Tract & PancreasAbdominal painDiarrhoea / steatorrhoeaDistensionLower GI Tract

11. Symptoms of Digestive DiseasesGeneralUpper GI TractLiver & BiliaryMid GI Tract & PancreasLower GI TractAbdominal painBleedingConstipationDiarrhoeaIncontinence

12. Signs of Digestive DiseasesGeneralCachexiaObesityLymphadenopathyAnaemiaJaundiceStigmata of chronic liver diseaseHandsAbdomenAnus & Rectum

13. Signs of Digestive DiseasesGeneralHandsKoilonychiaLeuconychiaClubbingPalmar erythemaDupytrens contractureTremorTachycardiaAbdomenAnus & Rectum

14. Signs of Digestive DiseasesGeneralHandsAbdomenOrgan enlargementMassTendernessDistensionAnus & Rectum

15. Signs of Digestive DiseasesGeneralHandsAbdomenAnus & RectumHaemorrhoidsFistulaFissureRectal massesProctitis

16. Williams, Roberts, Ali, et al. for the BSG. Gut 2007

17. General statistics5% of British adults suffer from long-standing illness of the digestive tract

18. General statisticsDigestive Diseases in UK are responsible for:12% of all deaths - totalling 64,061 in 20021 in 8 of all admissions to general hospitals 1 in 4 main operations within general hospitals

19. Contrasting Patterns of Major DiseasesWorldwideMalnutritionEnteric infectionsViral hepatitis and consequencesGastric cancerUKDyspepsia / indigestion / abnormal bowelsLiver disease due to alcohol and obesityColon cancer

20. Burden of DiseasePrevalence / IncidenceMorbidityReduced quality of lifeInability to workMortalityHealth costIndividualTaxpayer

21. Mortality Rates: England & Wales

22. Liver Deaths: England & Wales

23. Age-standardised MR from CLD in Different CountriesAge Standardised Mortality from Chronic Liver Disease. Selected countries. Latest available year010203040506070New ZealandNorwayAustraliaNetherlandsIsraelSwedenCanadaJapanSwitzerlandUK: E&WUSASpainPolandFinlandFranceLatviaDenmarkPortugalCzech RepublicGermanyAustriaLithuaniaGeorgiaEstoniaRep. KoreaSlovakiaCroatiaRussiaSloveniaAzerbaijanRomaniaHungaryKyrgyzstanRate per 100,000 populationSource: WHO, EuroStatFigures standardised to European Standard Population

24. Main Causes of Chronic Liver Disease in UK4 - 6% of UK population have abnormal LFTs: - Chronic hepatitis B (0.5 – 2.0%) - Chronic hepatitis C (0.4 – 1.0%)Increasing percentages with - Alcohol related steatohepatitis - Obesity related steatohepatitis (NAFLD)Complications of cirrhosis are the major cause of death in alcoholics

25. HBV Epidemiology350 Million chronically infected1 Million deaths per year

26. Outcome of HBV Infection10%30%70%Self limiting InfectionPersistent InfectionCirrhosis +/- HCCAsymptomatic Carriage90%10%Fulminant InfectionInfection<1%

27. Reprinted from Cohen J. Science. 1999;285:26.HCV EpidemiologyPrevalence Western Europe – 1.4 %US – 2 %Japan - 2 %Romania – 4.7%Egypt – 20%

28. Self limiting infectionPersistent infection20%80%ProgressiveNon-Progressive20%80%InfectionOutcome of HCV Infection

29. DyspepsiaCommon reason for 1o / 2o care consultationsHigh NHS costsEffects on Quality of LifeRisk of complications40% of adults suffer with dyspepsia2% consult their GP£600,000,000 for endoscopies and drugs£100,000,000 for OTC medications

30. Demographics of peptic ulcer, GORD & dyspepsiaJones RH, et al. Gut 1990; Jones R. Scand J Gastroenterol 1995; Nebel OT, et al. Dig Dis 1976; Penston JG, et al. Aliment Pharmacol Ther 1996LifetimePeptic ulcerLifetimeWeekDyspepsiaLifetimeGORDData from four separate studies105060403020 0% adult population70MonthWeek DayGORD

31. Gastro-oesophageal reflux disease (GORD)

32. What is Helicobacter pylori?Gram-negative, spiral bacteriumColonises the gastric mucosaInfection persists for life unless treated

33. EpidemiologyH. pylori is found in 50% of the world’s population.Geographic distribution is closely linked to socio-economic development.http://www.helico.com/

34. Chronic gastritis85% - no long term effects 14% - peptic ulceration1% gastric adenocarcinoma or lymphomaHelicobacter Related Disease

35. Gastric ulcer & cancers

36. Duodenal ulcer

37. Bleeding ulcerPeptic ulceration affects up to 10% populationEstimated to cause up to16,500 deaths each year in USA2,000 deaths each year in UKNSAIDS & H. pylori factors

38. UK Mortality from Cancer in the GI Tract

39. Colorectal Neoplasia

40. Colorectal NeoplasiaLifetime incidencePolyps 25%Carcinoma ~6%Genetic & dietary factorsPrevention by colonoscopic screeningSurgery for cancerPrognosis excellent at early stages (5 year survival)Duke’s A 95%Duke’s B 85%Duke’s C 50%Duke’s D 15%

41. Gastrointestinal CancersLiver cancermost is metastaticprimary liver cancer (hepatocellular and cholangio carcinomas) 2000 cases paprimary liver cell cancer (HCC) higher in cirrhosiscan be detected at an early stage by ultrasound scanning50% 5 year survivalcholangiocarcinoma increased 20 fold in last 20yrs; no treatment.

42. Cholangiocarcinoma: An increasing problem?ASMR of Intrahepatic Cholangiocarcinoma in males, England and Wales, 1968-1998

43. Gastrointestinal CancersPancreatic cancer95% adenocarcinoma of pancreatic ductdifficult to diagnose earlyone of the poorest survival rates (2% at 5y)

44. Inflammatory Conditions of the IntestineUlcerative colitis & Crohn's disease (IBD)1 in 400 people in the UK8,500 new cases are diagnosed every yearGenetic effects on intestinal immune responseMorbidity & increased mortalitySepsis, drugs and surgeryCoeliac Disease1% of UK populationGenetic sensitivityGluten-free diet

45. Crohn’s diseaseTerminal IleumColon

46. Ulcerative colitis; toxic megacolon

47. Duodenal Histology in Coeliac diseaseNormalCoeliac disease

48. Biliary Diseases and ConditionsGallstonesAbout one in ten people in Britainespecially women, overweight, middle aged or overBiliary colicCholecystitisObstructive jaundiceGallbladder carcinomaAcute pancreatitis

49. Pancreatic DiseasesAcute pancreatitisMild to life-threateningBlockage of pancreatic ductBack-up of pancreatic enzymes causing severe inflammationEthanol & gallstones in 80%Chronic pancreatitisPermanent damage to pancreasAlcohol excess main causeCan greatly impair Quality of Life

50. Intestinal Diseases and ConditionsAn estimated 200 million people around the world, on any given day, suffer from diarrhoeaWater and Food-borne infectionsVirusesBacteriaParasitesClean water supply essentialEnormous global indirect costs

51. Large Bowel Diseases & ConditionsIrritable bowel syndrome (IBS) IBS is very common1 in 3 of population at one time or another1 in 10 people suffer symptoms bad enough to go to a doctorConstipation-predominantDiarrhoea-predominantBloating / pain / mixed

52. Anal Diseases & ConditionsFaecal incontinence (soiling) may affect 1 in 20 peopleAbout half the population has haemorrhoids by age 50Over half the over 70's population of the UK have diverticula of the large intestine

53. Economic Burden of GI DiseaseWellcome Trust PRISM Project 1995/6Summary of costsMortality & lost yearsAbsence from workMorbidityNHS prescription costs

54. Population based mortality rates for major disease groupings, inEngland and Wales, 2000: people of all ages. Source: ONS, 2001.

55. Mortality from Digestive Diseases

56. Economic Burden of GI Disease in UK(BSG PRISM study – Wellcome Trust 1995/6; updated to 2004)Loss of productive work dying early £3.23 billionlong-term absence £1.05 billionshort-term absence £2.90 billion Total = £7.18 billionNHS costs in-patients £1.40 billionprimary care £0.14 billionDrugs £0.80 billion Total = £2.34 billion+ out-patients + community services Total > £10 billion

57. Cost of NHS PrescriptionsClasses of drug (BNF)AntacidsAntispasmodicsUlcer-healingChronic diarrhoeal agentsLaxativesHaemorrhoid treatmentStoma careIntestinal secretion drugsIn 2002, 60 million prescriptions for GI drugsTotal cost to NHS for drug alone was £802 million£596 million for ulcer-healing drugs£51 million for laxatives

58. Diseases of the Digestive TractDiverse group of conditionsMajor impact on healthSignificant economic burdenSignificant impact on Quality of Life